Mangoceuticals, Inc. Common Stock (MGRX) — Tangible Net Worth Ratio
Mangoceuticals, Inc. Common Stock (MGRX) has a Tangible Net Worth Ratio of -1.2% as of September 2025. This metric is calculated by deducting intangible assets ($15.92 Million) from net assets ($15.73 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Mangoceuticals, Inc. Common Stock shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Mangoceuticals, Inc. Common Stock Tangible Net Worth Ratio (2022–2024)
This chart shows how Mangoceuticals, Inc. Common Stock's Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2024. As of September 2025, the ratio stands at -1.2%, reflecting net assets of $15.73 Million with intangible assets of $15.92 Million USD. Also explore Mangoceuticals, Inc. Common Stock equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Mangoceuticals, Inc. Common Stock (2022–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Mangoceuticals, Inc. Common Stock from 2022 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see MGRX company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -9.2% | $13.95 Million | $15.23 Million | $15.37 Million | ▼ -109.2 pp |
| 2023 | 100.0% | $774.75K | $0.00 | $1.05 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $614.03K | $0.00 | $1.00 Million | — |